Studies from Optum, Inc. Yield New Data on Clinical Trials and Studies (Choosing Wisely Clinical Decision Support Adherence and Associated Inpatient…

Investment Weekly News

Studies from Optum, Inc. Yield New Data on Clinical Trials and Studies (Choosing Wisely Clinical Decision Support Adherence and Associated Inpatient Outcomes)

By a News Reporter-Staff News Editor at Investment Weekly News -- Investigators publish new report on Clinical Research - Clinical Trials and Studies. According to news originating from Washington, District of Columbia, by VerticalNews correspondents, research stated, "To determine whether utilization of clinical decision support (CDS) is correlated with improved patient clinical and financial outcomes. Observational study of 26,424 patient encounters."

Our news journalists obtained a quote from the research from Optum, Inc., "In the treatment group, the provider adhered to all CDS recommendations. In the control group, the provide did not adhere to CDS recommendations. An observational study of provider adherence to a CDS system was conducted using inpatient encounters spanning 3 years. Data comprised alert status (adherence), provider type (resident, attending), patient demographics, clinical outcomes, Medicare status, and diagnosis information. We assessed the associations between alert adherence and 4 outcome measures: encounter length of stay, odds of 30-day readmission, odds of complications of care and total direct costs. The associations between alert adherence and the outcome measures were estimated using 4 generalized linear models that adjusted for potential confounders such as illness severity and case complexity. The total encounter cost increased 7.3% (95% CI, 3.5%-11%) for nonadherent encounters versus adherent encounters. We found a 6.2% (95% CI, 3.0%-9.4%) increase in length of stay for nonadherent versus adherent encounters. The odds ratio for readmission within 30 days increased by 1.14 (95% CI, 0.998-1.31) for nonadherent versus adherent encounters. The odds ratio for complications increased by 1.29 (95% CI, 1.04-1.61) for nonadherent versus adherent encounters. Consistent improvements in measured outcomes were seen in the treatment group versus the control group."

According to the news editors, the research concluded: "We recommend that provider organizations consider the introduction of real-time CDS to support adherence to evidence-based guidelines, but because we cannot determine the cause of the associations between CDS interventions and improved clinical and financial outcomes, further study is required."

For more information on this research see: Choosing Wisely Clinical Decision Support Adherence and Associated Inpatient Outcomes. American Journal of Managed Care, 2018;24(8):361-366,127-132. American Journal of Managed Care can be contacted at: Managed Care & Healthcare Communications Llc, 666 Plainsboro Rd, Ste 300, Plainsboro, NJ 08536, USA.

The news correspondents report that additional information may be obtained from J. Kontor, Optum, Washington, DC 20001, United States. Additional authors for this research include A.M. Heekin, H.C. Sax, M.S. Keller, A. Wellington and S. Weingarten.

Keywords for this news article include: Washington, District of Columbia, United States, North and Central America, Clinical Trials and Studies, Investment and Finance, Health and Medicine, Clinical Research, Optum Inc., Business, Optum Inc.